Skip to content

Compare medicines

Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.

Attribute
In shortClassic antimalarial, still used for vivax malaria.Mild immune modulator for lupus and arthritis.
Body systemAntiparasiticsJoints & Immunity
Drug classAminoquinolinesConventional DMARDs
SupplyPrescription onlyWHO essential medicinePrescription onlyWHO essential medicine
Main usesP. vivax and P. ovale malaria, Malaria prevention (where sensitive), Amoebic liver abscessLupus, Rheumatoid arthritis, Sjögren's syndrome, Some skin conditions
How it worksStops the parasite detoxifying the blood it digests.Gently calms the immune system.
Starts working—2–3 months
Half-life1–2 monthsAbout 40 days
Typical adult doseTreatment: total 25 mg/kg base over 3 days, followed by primaquine for vivax.200–400 mg a day, not exceeding 5 mg/kg of actual body weight.
FormsTablet, Syrup, InjectionTablet
Common side effectsNausea, Headache, Itching (especially in people of African descent), Blurred visionNausea, Diarrhoea, Rash, Headache
Serious side effectsQT prolongation, Retinal damage with long-term use, Fatal in overdose, even in small amounts for childrenRetinal damage (long-term), QT prolongation, Low blood sugar
Don't take if—Allergy to 4-aminoquinolines; Pre-existing retinopathy; QT prolongation or interacting drugs
Alcohol—Usually no problem in moderation. No specific interaction.
PregnancyGenerally considered safeConsidered safe for malaria in pregnancy.Generally considered safeRecommended to continue in lupus — stopping raises flare risk.
Breastfeeding—Generally considered safeConsidered safe.
In use since19471955
Brand namesIndia: Lariago, ResochinUnited States: PlaquenilUnited Kingdom: Quinoric, PlaquenilIndia: HCQS, Hcqs
Legal status—United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H
ATC codeP01BA01P01BA02

Taken together

  • ModerateChloroquine + Hydroxychloroquine: Additive QT prolongation

    Both medicines can lengthen the QT interval. The risk is higher with heart disease, low potassium or magnesium, older age and female sex.

Open in the interaction checker